Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02920788 · ClinicalTrials.gov registry record · NA
Mild TBI Assessment & Rehabilitation
A NA study of Brain Injuries, Traumatic, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 63
- Enrollment target
- 2
- Study locations
NCT02920788: Active NA study of Brain Injuries, Traumatic, sponsored by VA Office of Research and Development.
NCT02920788 is a NA study of Brain Injuries, Traumatic that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 63 participants, below the 253-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02920788, a NA study of Brain Injuries, Traumatic, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
- 2
- Study locations
Study Summary
One of the most pressing concerns within the VA currently is the provision of interventions that address the cognitive as well as emotional problems faced by Veterans with mild TBI and comorbid conditions. When completed, these studies will inform us whether training core attentional self-regulatory control functions via personally-relevant activities will be effective in improving daily life for Veterans with mild TBI and comorbid conditions. The study design will provide a test not only of potential benefits for real life functioning, but also determine to what extent these benefits are related to actual changes in cognitive/behavioral performance and brain networks corresponding to these functions. This project will provide a foundation for future studies to investigate the neural mechanisms that support improvements of cognition and behavior in mTBI.
Primary Outcome
Single Test for Attention, Executive Function and Mental Flexibility
Conditions Studied
Interventions
- DEVICE fMRI
- BEHAVIORAL Goal-Oriented Attentional Self-Regulation (GOALS)
- OTHER Brain Health Education (BHE)
Study Locations (2)
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT02920788 still lists
NCT02920788 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 253-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 3 interventions - of which fMRI is the first listed.
NCT02920788 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02920788 about?
NCT02920788 is a clinical study titled "Mild TBI Assessment & Rehabilitation". One of the most pressing concerns within the VA currently is the provision of interventions that address the cognitive as well as emotional problems faced by Veterans with mild TBI and comorbid conditions. When completed, these studies will inform us whether training core attentional self-regulatory...
What is the current status of trial NCT02920788?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 63 participants. The study started on 2017-03-09. Estimated completion is 2026-04-30.
What conditions does trial NCT02920788 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT02920788?
The interventions under investigation include: fMRI (DEVICE), Goal-Oriented Attentional Self-Regulation (GOALS) (BEHAVIORAL), Brain Health Education (BHE) (OTHER).
Who is sponsoring clinical trial NCT02920788?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02920788 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02920788's enrollment target sits among peer trials
63 15th of 21 higher than 7 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
NEUROBALANCE Training to Improve Postural Control in Individuals With Traumatic Brain Injury
RECRUITING · NA
-
Brain Injury Education and Outpatient Navigation-1stBIEN
RECRUITING · NA
-
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI